BioCentury | Jul 17, 2019
Company News
On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas
...promote hair cell regeneration. In 2017, Astellas exercised an option to license worldwide rights from Auration Biotech Inc....
...growth factor (HBEGF; DTR). Allison Johnson, Senior Writer FX-322 Astellas Pharma Inc. Frequency Therapeutics Inc. Heparin-binding EGF-like growth factor (HBEGF) (DTR) AU-935 Auration Biotech Inc....
...growth factor (HBEGF; DTR). Allison Johnson, Senior Writer FX-322 Astellas Pharma Inc. Frequency Therapeutics Inc. Heparin-binding EGF-like growth factor (HBEGF) (DTR) AU-935 Auration Biotech Inc....
